Oral compositions containing dapiprazole

摘要

In an improved solid pharmaceutical composition for oral administration consisting of or made from a granulate comprising dapiprazole or a physiologically acceptable acid addition salt thereof together with at least one pharmaceutically acceptable inert excipient; the improvement comprises adding to said granulate a level of magnesium oxide capable of preventing or substantially reducing the degradation of dapiprazole or of the acid addition salt thereof.